Literature DB >> 28844814

Imaged capillary isoelectric focusing in native condition: A novel and successful example.

Xin Zhang1, Letha Chemmalil2, Julia Ding2, Nesredin Mussa2, Zhengjian Li2.   

Abstract

Imaged capillary isoelectric focusing (icIEF) separates ampholytic components of biomolecules in an electric field according to their isoelectric points and has been used for protein charge variants quantification and characterization. Denaturants are ordinarily incorporated into icIEF to stabilize charge species in solution. In certain circumstances, however, denaturants are detrimental to stable isoelectric separation of proteins due to their unique structural and biophysical features, such as an aggregation-prone antibody we encountered recently. Here we report our novel matrix formula non-detergent sulfobetaine and taurine (NDSB-T). It is deprived of denaturants that notably ameliorates the assay robustness and peak resolution for this antibody. NDSB-T is a combination of non-detergent sulfobetaine (NDSB) and taurine possessing the stabilization and separation power while maintaining protein integrity. As a result, assay throughputs are tremendously increased for more than 10 folds along with extraordinarily improved assay accuracy. Furthermore, NDSB-T can separate and quantify protein charge species in native state and therefore avoid partial denaturation derived peaks which are often misleading and hard to characterize. NDSB-T may be a valuable tool for proteins incompatible with conventional icIEF matrices and potentially opens a new window for icIEF assay in native conditions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Denaturants; NDSB; Native icIEF; Sulfobetaine; Taurine

Mesh:

Substances:

Year:  2017        PMID: 28844814     DOI: 10.1016/j.ab.2017.08.014

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

Review 1.  Challenges and new frontiers in analytical characterization of antibody-drug conjugates.

Authors:  Anil Wagh; Hangtian Song; Ming Zeng; Li Tao; Tapan K Das
Journal:  MAbs       Date:  2018-01-05       Impact factor: 5.857

2.  Targeting cancer with antibody-drug conjugates: Promises and challenges.

Authors:  Alexis Q Dean; Shen Luo; Julianne D Twomey; Baolin Zhang
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.